Halozyme (HALO) Q3 2026 Earnings Call Transcript
Merck patent setbacks in the U.S. cloud an otherwise strong quarter for royalties.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Clarus (CLAR) Q3 2026 Earnings Call Transcript
Strategic review and Outdoor growth define a mixed third quarter.
Power Solutions International (PSIX) Q3 2026 Earnings Call Transcript
Cash flow surged and debt fell, but management flagged softer margins ahead.
Ginkgo Bioworks (DNA) Q3 2026 Earnings Call Transcript
Ginkgo cut its quarterly loss 44% as it pivots to autonomous labs.
Microchip (MCHP) Q2 2027 Earnings Call Transcript
Industrial and data center demand pushed sales higher amid tight capacity.
Simon (SPG) Q3 2026 Earnings Call Transcript
Leasing momentum and rising rents lifted results despite higher interest costs.
Callaway (CALY) Q3 2026 Earnings Call Transcript
Debt reduction and margin gains lifted results despite weaker golf rounds.